COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Scott Weiner will present and sit on a panel at the IN3 Medical Device 360 conference on February 29th through March 2nd in Orlando, Florida.
News | 02. 08. 2012
Scott Weiner will present and sit on a panel at the IN3 Medical Device 360 conference on February 29th through March 2nd in Orlando, Florida.
